Interestingly, ADAM10 upregulation appears to play an important role in disease progression in various squamous cell cancers, such as oral SCC [78,79], tongue SCC [80], and non-small cell lung cancer [81]. Here, ADAM10 is linked to non-small cell lung carcinoma.